Landos Biopharma Q2 EPS $(0.63) Up From $(2.80) YoY
Portfolio Pulse from Benzinga Newsdesk
Landos Biopharma reported Q2 losses of $(0.63) per share, a 77.5% increase over losses of $(2.80) per share from the same period last year.
August 09, 2023 | 12:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Landos Biopharma's Q2 losses per share improved by 77.5% YoY, which may be seen as a positive sign by investors.
Landos Biopharma's Q2 losses per share have improved significantly compared to the same period last year. This indicates that the company's financial performance is improving, which could lead to a positive reaction from the market and potentially an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100